Limited Utility of Free Triiodothyronine Testing
The Journal of Applied Laboratory Medicine · 07.09.2023 · 8 (5) · 847-855
DOI: 10.1093/jalm/jfad032 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 20.07.2023. Verfasst von Yanchun Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO, United States. Hauptthemen laut MEDLINE: Hyperthyroidism, Thyrotoxicosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Free triiodothyronine (fT3) testing is most useful when thyroid stimulating hormone (TSH) is suppressed, and free thyroxine (fT4) is normal or decreased. These laboratory values in a symptomatic patient are referred to as T3 thyrotoxicosis. Standards for fT3 reflex testing have not been established. Herein, we examined the clinical utility of fT3 with the goal of identifying a TSH cutoff in the context of normal/decreased fT4 that maximizes the utility of measuring fT3.
Methods
TSH, fT4, and fT3 results between January 2016 and October 2021 were extracted from the laboratory information system and grouped if resulted on the same day for the same patient. Frequency of biochemical T3 thyrotoxicosis was evaluated at different TSH cutoffs and in outpatient vs inpatient settings.
Results
Of the 4366 TSH-fT4-fT3 results, 70 (1.6%) were consistent with biochemical T3 thyrotoxicosis. The common reasons were previously diagnosed hyperthyroidism on antithyroid medication (n = 28) or hypothyroidism on thyroid medication (n = 18) and newly diagnosed hyperthyroidism (n = 20, 0.5%). The likelihood of detecting T3 thyrotoxicosis increased with lower TSH cutoff (<0.3 μIU/mL, 10.3% vs <0.0 1μIU/mL, 27.6%). All patients with newly diagnosed hyperthyroidism had TSH <0.01 μIU/mL. Higher frequency of T3 thyrotoxicosis was observed in the outpatient setting (34%) relative to the inpatient setting (14%, P < 0.001) when TSH < 0.01 μIU/mL.
Conclusions
T3 thyrotoxicosis is a relatively rare diagnosis and fT3 measurement has limited utility in the vast majority of patients. A fT3 reflex for patients with TSH <0.01 μIU/mL and normal/low fT4 may improve clinical utility and reduce unnecessary testing, especially in the outpatient setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology & Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO, United States.
- Department of Medicine, Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, MO, United States.
Zitieren
APA
Lin, Y., Riek, A. E., Gronowski, A. M., & Farnsworth, C. W. (2023). Limited Utility of Free Triiodothyronine Testing. The Journal of Applied Laboratory Medicine, 8(5), 847-855. https://doi.org/10.1093/jalm/jfad032
Vancouver
Lin Y, Riek AE, Gronowski AM, Farnsworth CW. Limited Utility of Free Triiodothyronine Testing. The Journal of Applied Laboratory Medicine. 2023;8(5):847-855. doi:10.1093/jalm/jfad032
BibTeX
@article{Lin2023,
author = {Lin, Yanchun and Riek, Amy E and Gronowski, Ann M and Farnsworth, Christopher W},
title = {Limited Utility of Free Triiodothyronine Testing},
journal = {The Journal of Applied Laboratory Medicine},
year = {2023},
volume = {8},
number = {5},
pages = {847--855},
doi = {10.1093/jalm/jfad032}
}
EUVIMED